| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |